Stocklytics Platform
FBT
First Trust NYSE Arca Biotechnology Index Fund
FBT
$171.56arrow_drop_up0.08%$0.15

Performance History

Chart placeholder
Key Stats
Open$171.42
Prev. Close$171.40
EPS-
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
PE Ratio-
LOWHIGH
Day Range170.97
173.41
52 Week Range130.27
173.41
Ratios
P/B Ratio-
Revenue-
Operating M. %-
Earnings-
Earnings Growth %-
EBITDA Margin %-
ROE %-
EPS-

About First Trust NYSE Arca Biotechnology Index Fund (FBT)

The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund (ETF) that seeks to provide investment results that correspond generally to the price and yield of the NYSE Arca Biotechnology Index. The index is designed to track the performance of biotechnology and pharmaceuticals companies listed on the New York Stock Exchange (NYSE) and NASDAQ Stock Market (NASDAQ). FBT offers investors exposure to a diverse range of companies involved in the research, development, manufacturing, and distribution of drugs, therapies, and other life sciences products.
With a history dating back to 2006, FBT has become a popular choice for investors looking to gain exposure to the biotechnology industry. The fund aims to provide investors with a convenient and cost-effective way to invest in a diversified portfolio of biotech stocks. FBT has a strong track record of performance, as it has consistently outperformed its benchmark index over the long term.
Sector
Industry
CEO
Headquarters
Employees
0
Exchange
NYSE

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

add First Trust NYSE Arca Biotechnology Index Fund to watchlist

Keep an eye on First Trust NYSE Arca Biotechnology Index Fund

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

News

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level

Stocklytics Platform

© 2024 Stocklytics.com All rights reserved.

Stocklytics.com is not a financial advisor, and all data and information provided on this website are for informational purposes only. The content on Stocklytics.com is not intended to be a substitute for professional financial advice. Investors should conduct their own research and consult with a qualified financial advisor before making any investment decisions. Stocklytics.com makes no representations or warranties regarding the accuracy, completeness, or suitability of any information provided and is not liable for any errors or omissions, or for any losses incurred as a result of reliance on the information provided on this website.

Stocklytics Discord public channelStocklytics X Social Media